NewsBenzinga아이오밴스 바이오테라퓨틱스, ESMO 2026에서 전이성 UPS 및 DDLPS 환자 대상 리필루셀 단독요법의 깊고 지속적인 반응 보고 아이오밴스 바이오테라퓨틱스, ESMO 2026에서 전이성 UPS 및 DDLPS 환자 대상 리필루셀 단독요법의 깊고 지속적인 반응 보고 Benzinga 2026.10.26 11:05 (GMT+0) Open on Benzinga Other news Huobi HTX to Open Spot Trading for SOXS, KORU and SNXX on November 17 Duan Yongping Trims Nvidia and Apple in Q3, Exits Alibaba and CRCL, Opens New SpaceX Stake Ethereum Glamsterdam upgrade testing finds bug: some internal payments skipped while transaction succeeds US Says Justice Leads Megaspeed AI-Chip Investigation Soluna Holdings, Inc. (SLNH) Q3 2026 Earnings Call Transcript ‘The Odds Are Almost Zero’: Scott Galloway Doesn’t See Jensen Huang Returning to Nvidia
Ethereum Glamsterdam upgrade testing finds bug: some internal payments skipped while transaction succeeds